• 3728 Citations
  • 37 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ana Lleo De Nalda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Biliary Liver Cirrhosis Medicine & Life Sciences
Autoimmune Diseases Medicine & Life Sciences
Autoimmunity Medicine & Life Sciences
Cholangitis Medicine & Life Sciences
Autoantibodies Medicine & Life Sciences
Sclerosing Cholangitis Medicine & Life Sciences
Liver Medicine & Life Sciences
Epigenomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

7 Citations (Scopus)

Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals

Lleo, A., Aglitti, A., Aghemo, A., Maisonneuve, P., Bruno, S., Persico, M., Rendina, M., Ciancio, A., Lampertico, P., Brunetto, M. R., Di Marco, V., Zuin, M., Andreone, P., Villa, E., Troshina, G., Degasperi, E., Coco, B., Calvaruso, V., Giorgini, A. M., Conti, F. & 5 others, Di Leo, A., Marzi, L., Boccaccio, V., Bollani, S. & Colombo, M., 2019, In : Digestive and Liver Disease. 51, 2, p. 310-317

Research output: Contribution to journalArticle

Antiviral Agents
Hepatocellular Carcinoma
Portal Hypertension
1 Citation (Scopus)

Safety of vedolizumab in liver transplant recipients: A systematic review

Spadaccini, M., Aghemo, A., Caprioli, F., Lleo, A., Invernizzi, F., Danese, S. & Donato, M. F., Jan 1 2019, In : United European Gastroenterology Journal. 7, 7, p. 875-880

Research output: Contribution to journalReview article

Inflammatory Bowel Diseases
1 Citation (Scopus)

Changes in the Epidemiology of Primary Biliary Cholangitis

Lleo, A. & Colapietro, F., Aug 1 2018, In : Clinics in Liver Disease. 22, 3, p. 429-441 13 p.

Research output: Contribution to journalReview article

Sex Ratio
Autoimmune Diseases
Disease Progression
9 Citations (Scopus)

High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma

Persico, M., Aglitti, A., Aghemo, A., Rendina, M., Lleo, A., Ciancio, A., Di Marco, V., Lampertico, P., Brunetto, M. R., Zuin, M., Andreone, P., Villa, E., Troshina, G., Calvaruso, V., Degasperi, E., Coco, B., Giorgini, A., Conti, F., Di Leo, A., Marzi, L. & 4 others, Boccaccio, V., Bollani, S., Maisonneuve, P. & Bruno, S., Jun 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 12, p. 1705-1712 8 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Intention to Treat Analysis
Hepatic Encephalopathy

Is Liver Injury an Affordable Risk of Immune Checkpoint Inhibitor Therapy for Cancer?

Colombo, M. & Lleo, A., Dec 2018, In : Gastroenterology. 155, 6, p. 2021-2023 3 p.

Research output: Contribution to journalArticle